Abuse Potential Assessment of Intranasally Administered EMBEDA Compared To Morphine Sulfate Controlled Release And Placebo

NCT01595867 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Narcotic Abuse
Opioid-related Disorders
Analgesia
Chronic Pain

Interventions

DRUG: Placebo
DRUG: EMBEDA - morphine sulfate/ naltrexone hydrochloride
DRUG: morphine sulfate CR crushed.

Sponsor

Pfizer